|
?:authorAffiliation
|
-
[\'Department of Clinical Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, SP, Brazil; BioLambda, Scientific and Commercial LTD, São Paulo, SP, Brazil. Electronic address: caetano@biolambda.com.\', \'GAMA Therapeutics LLC, Massachusetts Biomedical Initiatives, Worcester, USA.\', \'Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil.. Electronic address: baptista@iq.usp.br.\', \'Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.\', \'Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa.\', \'Center for Lasers and Applications, Nuclear, and Energy Research Institute, National Commission for Nuclear Energy, São Paulo, SP, Brazil.\', \'GAMA Therapeutics LLC, Massachusetts Biomedical Initiatives, Worcester, USA; Department of Chemistry Rice University, Houston, TX, USA; IdISBA - Fundación de Investigación Sanitaria de las Islas Baleares, Palma, Spain.\', \'Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, SP, Brazil; School of Veterinary Medicine, Metropolitan University of Santos, Santos, Brazil.\', \'GAMA Therapeutics LLC, Massachusetts Biomedical Initiatives, Worcester, USA; Micromoria LLC, Marlborough, USA.\', \'School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}